Health Canada open data (page 24)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Updates to list of medical devices for mandatory shortage reporting: Notice
- Risk classification guide for medical device establishment inspections GUI-0079
- How Health Canada inspects medical device establishments: Overview
- How Health Canada inspects medical device establishments: About inspections
- How Health Canada inspects medical device establishments: Assessing compliance with the Food and Drugs Act
- How Health Canada inspects medical device establishments: Assessing compliance with the Medical Devices Regulations
- Cancellation of MDELs for failure to pay fees
- Health Canada updates list of medical devices for mandatory reporting of shortages
- Health Canada is modernizing and transforming the Medical Devices Compliance Program
- New labelling and MDEL requirements for medical devices authorized under interim orders on September 1, 2021
- Guidance on Medical Device Establishment Licensing (GUI-0016) - Summary
- Guidance on Medical Device Establishment Licensing (GUI-0016)
- Fees for the Review of Medical Device Establishment Licence Applications
- Fees for the Review of Medical Device Establishment Licence Applications
- Forward Regulatory Plan 2022-2024: Modernizing the Medical Device Establishment Licensing (MDEL) Framework
- Process Validation: Form-Fill-Seal for Drugs (GUI-0008)
- 2017 report on compliance monitoring: Good manufacturing practices for natural health products
- Annex 11 to the good manufacturing practices guide: Computerized Systems: GUI-0050
- Annex 7 to the Good manufacturing practices guide for drug products - Selected non-prescription drugs
- Canada and EU recognize good manufacturing practices extra-jurisdictional inspection outcomes before April 1, 2021
- Notice of publication: Good manufacturing practices guidelines for active pharmaceutical ingredients
- Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary
- Drug quality and supply chain requirements in light of Russia's invasion of Ukraine
- Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)
- 2018-2019 Compliance monitoring project: Good manufacturing practices for natural health products
- Annex 3B to the Good manufacturing practices guide – Positron-emitting radiopharmaceuticals
- Mutual Recognition Agreement Evaluation Guide of Good Manufacturing Practices Compliance Programs
- Drug shortages in Canada: Information for health care providers
- Drug shortages in Canada: Information for industry
- Drug shortages in Canada: Multi-stakeholder steering committee
- Drug shortages in Canada: Regulations and guidance
- Guide to validation – drugs and supporting activities (GUI-0029)
- Guide to validation – drugs and supporting activities (GUI-0029) - Summary
- Health products compliance: International agreements and collaboration activities
- Good Manufacturing Practices (GMP) - Inspection Summary Reports
- Fentanyl
- Naloxone
- GHB
- Heroin
- Ketamine
- LSD
- MDMA
- Methamphetamine
- Expert Advisory Group on Marketing of Opioids
- Expert Advisory Group on Marketing of Opioids - Summary of Expertise, Affiliations and Interests
- Measuring the impact of the opioid overdose epidemic on life expectancy at birth in Canada
- New Model for Opioid Dependence Treatment in Newfoundland and Labrador
- Highlights from phase one of the national study on opioid and other drug-related overdose deaths: insights from coroners and medical examiners
- Supervised consumption explained: types of sites and services
- Supervised consumption sites and services